Overview

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective is to study the effectiveness of Nalmefene in decreasing alcohol intake in subjects with alcohol use disorder and comorbid BPD.
Phase:
N/A
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborator:
Hospital Universitari General de Catalunya
Treatments:
Nalmefene
Naltrexone